A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients
Clinical trial NCT01209832 · TERMINATED
Trial details
- NCT number
- NCT01209832
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-01-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.